发明名称 A new compound FR-68504, production thereof and use thereof.
摘要 <p>57 The invention relates to a new compound, designated FR-68504. The compound has antitumor activities and is effective in the treatment of various tumors in both human beings and animals.</p><p>There is also provided a process for preparing FR-68504 compound which comprises culturing a FR-68504 producing strain belonging to the genus Amauroascus in a nutrient medium.</p><p>Pharmaceutical composition comprising FR-68504 as an active ingredient is also described.&lt;!-- EPO &lt;DP n="2"&gt; --&gt;</p><p>&lt;UnorderedLists id="ula01" listStyle="none"&gt;&lt;ListItem&gt;f) UV absorption spectrum : &lt;UnorderedLists id="ula02" listStyle="none"&gt;&lt;ListItem&gt;End absorption (in H&lt;Sub&gt;2&lt;/Sub&gt;0)&lt;/ListItem&gt;&lt;/UnorderedLists&gt;&lt;/ListItem&gt;&lt;ListItem&gt;g) IR absorption spectrum : &lt;UnorderedLists id="ula03" listStyle="none"&gt;&lt;ListItem&gt;Nujol: 3400, 3250, 1300, 1100, 1030, 950, max 850 cm-1&lt;/ListItem&gt;&lt;/UnorderedLists&gt;&lt;/ListItem&gt;&lt;ListItem&gt;h) &lt;Sup&gt;1&lt;/Sup&gt;H NMR absorption spectrum : (D&lt;Sub&gt;2&lt;/Sub&gt;0) δppm: 3.94-3.78 (4H, m), 3.57 (lH, dd, J=9.2 and 5.3Hz), 3.36-3.25 (2H, m), 3.01-2.88 (4H, m)&lt;/ListItem&gt;&lt;ListItem&gt;i) 13&lt;Sub&gt;C NMR&lt;/Sub&gt; absorption spectrum : (D&lt;Sub&gt;2&lt;/Sub&gt;0) δppm: 71.0 (d), 70.6 (d), 70.4 (d), 69.6 (d), 68.6 (d) , 55.1 (d), 53.5 (d) , 46.6 (t), 46.5 (t)&lt;/ListItem&gt;&lt;ListItem&gt;j) Solubility : &lt;UnorderedLists id="ula04" listStyle="none"&gt;&lt;ListItem&gt;Soluble : Water&lt;/ListItem&gt;&lt;ListItem&gt;Sparingly soluble : Methanol, ethanol, acetone&lt;/ListItem&gt;&lt;ListItem&gt;Insoluble : Ethyl acetate, chloroform&lt;/ListItem&gt;&lt;/UnorderedLists&gt;&lt;/ListItem&gt;&lt;ListItem&gt;k) Color reaction : &lt;UnorderedLists id="ula05" listStyle="none"&gt;&lt;ListItem&gt;Positive : Molish's reaction, reaction with cerium sulfate&lt;/ListItem&gt;&lt;ListItem&gt;Negative : Ninhydrin reaction, ferric chloride-potassium ferricyanide reaction, reaction with Dragendorff reagent or iodine vapor.&lt;/ListItem&gt;&lt;/UnorderedLists&gt;&lt;/ListItem&gt;&lt;ListItem&gt;1) Property of substance : &lt;UnorderedLists id="ula06" listStyle="none"&gt;&lt;ListItem&gt;Neutral substance&lt;/ListItem&gt;&lt;ListItem&gt;m) Thin layer chromatography (silica gel sheet) :&lt;Image id="ia01" he="28" wi="141" file="IMGA0001.TIF" imgContent="table" imgFormat="TIFF" inline="no" /&gt;&lt;/ListItem&gt;&lt;/UnorderedLists&gt;&lt;/ListItem&gt;&lt;/UnorderedLists&gt;</p><p>The FR-68504 can be prepared by culturing a FR-68504-producing strain belonging to the genus</p>
申请公布号 EP0187528(A2) 申请公布日期 1986.07.16
申请号 EP19850309460 申请日期 1985.12.23
申请人 FUJISAWA PHARMACEUTICAL CO., LTD. 发明人 KIYOTO, SUMIO;MURAI, HIDETSUGU;TSURUMI, YASUHISA;TERANO, HIROSHI FUJISAWA PHARMACEUTICAL CO. LTD.;KOHSAKA, MASANOBU
分类号 C12N1/16;A61K36/06;A61K36/07;A61P35/00;C07G11/00;C12N1/14;C12P1/02;C12R1/645;(IPC1-7):C12P1/02;A61K35/66 主分类号 C12N1/16
代理机构 代理人
主权项
地址